BAGELLA, Paola
 Distribuzione geografica
Continente #
NA - Nord America 536
EU - Europa 316
AS - Asia 139
OC - Oceania 2
AF - Africa 1
SA - Sud America 1
Totale 995
Nazione #
US - Stati Uniti d'America 529
IT - Italia 108
UA - Ucraina 93
CN - Cina 86
SG - Singapore 42
DE - Germania 39
FR - Francia 15
FI - Finlandia 9
RO - Romania 9
CZ - Repubblica Ceca 8
BE - Belgio 7
GB - Regno Unito 7
CA - Canada 6
TR - Turchia 6
SE - Svezia 4
AU - Australia 2
ES - Italia 2
HU - Ungheria 2
IN - India 2
LT - Lituania 2
LU - Lussemburgo 2
NL - Olanda 2
BG - Bulgaria 1
BT - Bhutan 1
CH - Svizzera 1
CL - Cile 1
IE - Irlanda 1
IL - Israele 1
KR - Corea 1
MD - Moldavia 1
MX - Messico 1
NG - Nigeria 1
PL - Polonia 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 995
Città #
Chandler 159
Jacksonville 55
Singapore 40
Dearborn 33
Princeton 32
Sassari 32
Ann Arbor 23
Ashburn 18
Nanjing 17
Wilmington 16
New York 14
Cagliari 12
Beijing 10
Nanchang 9
Brno 8
Brussels 7
Rome 7
Tianjin 7
Izmir 6
Santa Clara 6
Shenyang 6
Changsha 5
Città Di Castello 5
Turin 5
Boardman 4
Hebei 4
Ningbo 4
Toronto 4
Woodbridge 4
Gonnosfanàdiga 3
Guangzhou 3
Jiaxing 3
Munich 3
Andover 2
Budapest 2
Helsinki 2
Jinan 2
Lanzhou 2
Los Angeles 2
Luxembourg 2
Orani 2
Paris 2
Shanghai 2
Siliqua 2
Taizhou 2
Washington 2
Zhengzhou 2
Adliswil 1
Alghero 1
Amsterdam 1
Baotou 1
Beaverton 1
Bologna 1
Boston 1
Changchun 1
Chengdu 1
Chisinau 1
Dallas 1
Dublin 1
Edinburgh 1
Frankfurt am Main 1
Hamburg 1
Hangzhou 1
Huskvarna 1
Irvington 1
Isernia 1
Lagos 1
Leawood 1
Madrid 1
Mexico 1
Miami 1
Milwaukee 1
Montreal 1
Mountain View 1
New Orleans 1
Norbello 1
Oklahoma City 1
Ottawa 1
Pharr 1
Selargius 1
Seoul 1
Settimo San Pietro 1
Sofia 1
St Louis 1
Stockholm 1
Sydney 1
Tel Aviv 1
Thimphu 1
Villanovafranca 1
Warsaw 1
Zhoushan 1
Totale 636
Nome #
Enzyme biosensors for biomedical applications: Strategies for safeguarding analytical performances in biological fluids 116
Underserved populations and bacterial and protozoal sexually transmitted infections: a lost health-care opportunity 93
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 90
HEPATOCELLULAR CARCINOMA DEVELOPMENT IN A PATIENT WITH HCV INFECTION AFTER ERADICATION WITH DIRECT-ACTING ANTIVIRAL AGENTS 80
Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials 77
Evaluation of EZH2 expression in hepatitis B patients 64
Editorial - Non AIDS-defining malignancies: a new epidemic in HIV-infected population for the upcoming decades? 64
Mucocutaneous leishmniasis as presentation of HIV infection in Sardinia, insular Italy 63
Analisi delle Dual Therapy nei pazienti con HIV: Aspetti farmacoeconomici-epidemiologici e clinici 61
Mediterranean spotted fever-like illness in Sardinia, Italy: a clinical and microbiological study 60
Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B 60
Tache Noire in a Patient with Acute Q Fever 57
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project 47
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 41
Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV-infected patients in clinical practice: results from a multicentre, observational study 39
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 31
HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project 30
Totale 1.073
Categoria #
all - tutte 5.246
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.246


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020130 0 0 0 0 16 24 39 3 16 13 17 2
2020/2021118 16 2 15 1 19 1 19 3 21 19 2 0
2021/202292 9 2 0 2 1 0 5 9 9 5 18 32
2022/2023282 19 36 5 66 8 44 5 33 34 7 20 5
2023/202485 12 7 4 3 17 9 9 3 0 0 10 11
2024/202585 11 7 27 21 19 0 0 0 0 0 0 0
Totale 1.073